Abiomed Inc (NASDAQ:ABMD) - Overview

Stock Report

Abiomed Inc ABMD

Last Price
$108.87

Day Change
1.48|1.38%

As of 02/12/2016
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close107.39
Day Range106.80 - 109.83
Mkt Cap4.72Bil
52-Wk Range67.81 - 132.95
Yield %-
ISINUS0036541003
Volume460,155
P/E112.24
P/S12.63
P/CF53.15

Share Price

Financials
201420152016
More ...
Income Statement
Revenue183.64230.31329.54
Operating Income8.3628.6765.10
Net Income7.35113.6938.15
Basic EPS0.192.800.90
Avg. Diluted Shares Outstanding424345
Balance Sheet
Current Assets117.97220.14288.39
Non Current Assets87.44118.23135.54
Total Assets205.41338.37423.93
Current Liabilities30.4139.3246.54
Total Liabilities37.0546.8155.16
Total Equity168.35291.56368.78
Cash Flow
Operating Cash Flow23.4743.2976.80
Capital Expenditure-2.76-5.19-15.62
Free Cash Flow20.7138.1061.17

In millions, except "Basic EPS". Currency is USD.

Company Profile

Abiomed Inc is engaged in providing mechanical circulatory support devices and it offers a continuum of care in heart recovery to heart failure patients.

Sector

Healthcare

Industry

Medical Devices

Stock Style

Mid-Growth

Fiscal Year Ends

March

Employees

747
Key Stats
More ...
Price/Earning TTM106.33
Price/Book11.69
Price/Sales TTM13.48
Rev Growth (3 year avg)27.73
EPS Growth (3 year avg)-
Operating Margin % TTM19.76
Net Margin % TTM11.58
ROE TTM11.55
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.